Bile acid synthesis impedes tumor-specific T cell responses during liver cancer
Varanasi, Siva Karthik, Chen, Dan, Liu, Yingluo, Johnson, Melissa A., Miller, Cayla M., Ganguly, Souradipta, Lande, Kathryn, LaPorta, Michael A. +25 more·2025·Science
Cited by (174)
Items 101–174 of 174
- Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.Qing Li, Rodrigo de Oliveira Formiga, H. Sokol · 2026 · Trends in immunology
- GOLM1 and bile acid synthesis: Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”2025
- Radiopaque microsphere-hydrogel composite for extended-release intratumoral immunotherapy in a large animal model2026
- Decoding the microbiome-immune crosstalk in cancer: from mechanisms to therapeutic translationNing Zhao, Liang Wu, Sha Peng, Hui Yang, 宋永春, Yong Zhang, Lingwen Ding · 2026 · Biomarker Research
- Regulation of immune tolerance in hepatocellular carcinoma by liver diseases: a reviewJinyi Li, Yuanda Liu · 2026 · Infectious Agents and Cancer
- MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort studyHong Wei, Subin Heo, Yang Yang, Mengsi Li, Fangfang Fu, Tianyi Xia, Seung Soo Lee, Eun Sun Choi, Riccardo Sartoris, Jules Grégory et al. · 2026 · Journal of Hepatology
- EID1 blockade potentiates immunosurveillance against cancer metastasis via FPR1-mediated DC-NK crosstalkZiqi Jin, Xiao Zhang, Huijuan Zhang, Siying Qin, Siqi Zhang, Shuqing Zhang, Lin Xia, Peipei Li, Wen Xu, Peng Liu et al. · 2026 · Science China Life Sciences
- Spatial dynamics of the tumor microenvironment linked to emerging resistance in EGFR -mutated lung cancerSatoshi Nakamura, Daisuke Shibahara, Kentaro Tanaka, Yasuyuki Kishikawa, Mikiko Hashisako, Keita Nakatomi, Noriaki Nakagaki, Mikihiro Kohno, Koichi Azuma, Ritsu Ibusuki et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
- Immune cytokines as a bridge linking the gut–liver–ovary axis in the pathogenesis of premature ovarian failureHuimin Xu, Muxi Li, Shouyan Yang, Deyou Jiang · 2026 · Frontiers in Endocrinology
- Toward Microbiome-Informed Melanoma Care: The Gut Microbiota in Melanoma Evolution, Immunotherapy Response and Immune-Related ToxicityDimitrios C. Ziogas, Charalampos Theocharopoulos, Anastasios Martinos, Georgios Lyrarakis, Dimitra T. Stefanou, Amalia N. Anastasopoulou, Helen Gogas · 2026 · Current Oncology Reports
- Integrative Profiling of Metabolic CYP Expression, DNA Mutation Rates, and Immune Cell Infiltration for Survival Prognosis in Hepatocellular CarcinomaMona Dawood, Axel Guthart, Edna Ooko, Ralf Weiskirchen, Thomas Efferth, Joelle C. Boulos · 2026 · Livers
- Gut microbial metabolites for potentiating cancer therapyStephan Kamrad, Nicola Gagliani, Trevor D. Lawley, Kiran Raosaheb Patil, Joseph Tintelnot · 2026 · Trends in cancer
- Bile acid species as hepatic T lymphocyte response modulators – when bile acids interfere with tumor growthDavid C. Trampert · 2025 · Journal of Hepatology
- Single-cell RNA sequencing and spatial transcriptomic analysis reveal a distinct population of G6PD+ cells with aberrant bile acid metabolism in hepatocellular carcinomaXing Jiang, Haiyan Quan, Ting Yin, Hailun Yao, Yajun Li, Bin Peng, Xinye Yuan, Weiguang Zeng, Honghui Chen, Rong Li · 2026 · Frontiers in Immunology
- Harnessing the gut microbiota to enhance immune checkpoint inhibitor efficacy: from mechanistic insights to clinical translationQinsheng Bi, L Zhang, Hejia Wan, Jiaxin Zhang · 2026 · Molecular Biology Reports
- Resveratrol Alleviates Arsenic-Induced Liver Fibrosis in Rats by Correcting SIRT1-Mediated Disorder of Hepatic Bile Acid MetabolismQi Wang, Hualin Chen, Qiming Ran, Fang Hu, Qiwen Fu, Lu Ma · 2026 · International Journal of Molecular Sciences
- Bile Acids and Healthy AgeingBrecht J. Attema, Folkert Kuipers · 2026 · Engineering
- Molecular insights into early malignant transition of hepatocellular carcinomaZhengtao Zhang, Hong Li, Ling-Li Chen, Tao Lu, Xinyi Shentu, Yuan-Hua Liu, S. Ji, Zhixin Qiu, Yi-Ning Zou, Hong-Lin Wen et al. · 2025 · bioRxiv
- A translational model of MASLD-associated HFpEF defines mitochondrial dysfunction and cardiac plasticity during disease progression and regressionSouradipta Ganguly, Betul Beyza Gunes, Yusu Gu, Jorge Suárez, Gautam Gupta, Kei Ishizuka, Rabi Murad, Tatiana Kisseleva, Wolfgang H. Dillmann, Kirk L. Peterson et al. · 2026 · Metabolism
- Advances in bile acid metabolism-mediated immunomodulationLu BAI, Fang Yang, Leng HAN, Cheng GUO, Quan-Jun YANG · 2026 · Shengming kexue
- Bile acid metabolism and invasion-related genes as therapeutic monitoring biomarkers in non-small cell lung cancerGuangteng Wu, Lin Zhu, Feng Xue, Yanyi Zhao · 2025 · Discover Oncology
- Screening of known gut microbiome-derived metabolites in anti-tumor immunity of colorectal cancerXinan Zhang, Zixuan Li, Hui Hua, Hao Song, Sangni Qian, Xin Huang, Guiqin Ye, Yingyu Huang, Qin Wang, Boan Zheng et al. · 2026 · Journal for ImmunoTherapy of Cancer
- Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage ModulationYi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, Atsuo Sai, Takuma Irie, Takumi Habu, Shota Fukuoka, Atsushi Kumanogoh, Naoya Sakamoto, Genichiro Ishii et al. · 2026 · Cancer Immunology Research
- Dysregulated Lipid Metabolism in Hepatocellular Carcinoma: Mechanisms and Therapeutic StrategiesYi Yi, Xi Liu, Xi Zhang, Yongsheng Li, Huakan Zhao · 2026 · MedComm – Oncology
- Deoxycholic acid impairs mitochondrial fitness and suppresses mitophagy through Parkin ubiquitination driving CD8+ T cell Exhaustion in Colorectal CancerGao Y, Jiaxin Wang, Shihui Lai, Mingwei Li, Shi Jl, Xianjun Li, Ying Guo, Sainan Ma, Xinxin Wang, Shule Zhang et al. · 2026 · Redox Biology
- Click chemistry approach to bioactive conjugates of bile acids and sterolsAnna Kawka, Hanna Koenig, Tomasz Pospieszny · 2026 · Studies in natural products chemistry
- Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventionsChuying Yu, Xintong Ye, Haoyu Zhao, 钱素婷, Feifei Xie, Qingsheng Liu · 2026 · Frontiers in Endocrinology
- A new incompatible combination: Reynoutria multiflora combined with Cullen corylifolium enhances idiosyncratic hepatotoxicity under immunological stress2025
- Discovery and Validation of COL11A1 as a Therapeutic Target for Sorafenib Resistance in Lung Adenocarcinoma2026
- The interplay between lipid metabolism, cancer progression and anti-cancer immunityChoong‐Hyun Koh, Yoosun Lee, Il‐Kyu Kim, Yeonseok Chung · 2026 · Experimental & Molecular Medicine
- The conjugation-resistant bile acid norUDCA cures liver fibrosis but impairs systemic energy metabolismJöerg Heeren, Ioannis Evangelakos, Esther Verkade, Folkert Kuipers, Julia Sarah Rohde, Markus Heine, Anna Worthmann, Sebastian Graute, Manka M. Fuh, Karthikeyan Gunasekaran et al. · 2025 · Research Square
- Chenodeoxycholic acid restrains tumor growth via TGR5-dependent type 1 dendritic cells cross-primingFanlian Zeng, Fulei Zhao, Pei Zhou, Ya Li, Xiaoyan Wang, Yawen Hu, Jiadong Yu, Guolin Li, Chengcheng Yue, Yuting Feng et al. · 2026 · Signal Transduction and Targeted Therapy
- Antibiotic-induced gut microbiota dysbiosis and bile acid metabolism: implications for intestinal health, immune regulation, and disease susceptibilityTareq Nayef AlRamadneh, Jasur Rizaev, Malathi Hanumanthayya, Maryam Abdul Al-Hussein, Ahmed Faisal Mutee, Mukhammadali Buriev, Nasiba Jumaniyazova, Shefali · 2026 · Frontiers in Microbiology
- On the use of UDCA beyond cholestatic liver disease: How bile acid-driven intestinal GLP-1 signalling keeps the joints healthyDavid C. Trampert · 2026 · Journal of Hepatology
- Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and DiabetesMario Romeo, Claudio Basile, Giuseppina Martinelli, Fiammetta Di Nardo, Carmine Napolitano, Alessia De Gregorio, Paolo Vaia, Luigi Di Puorto, Mattia Indipendente, Alessandro Federico et al. · 2026 · Cancers
- Chemical dissection of sterol and bile acid signaling via clickable photoaffinity probesMiaomiao Xu, Xiaoming Chen, Jian Ma, Xinglin Yang · 2025 · Biophysics Reports
- Mechanisms and Clinical Significance of Bile Acid Metabolism Reprogramming in Hepatocellular Carcinoma Immunotherapy ResponseTianmin Zhou, Ruixin Wang, Hao Wei, Wenli Liu, Yingqun Xiao, Qingmei Zhong, Zhuoqi Liu, Daya Luo, Kunpeng Jiang, Ping Zhang et al. · 2026 · Research Square
- Microbial Signals in Cancer: Dissecting Host–Microbiota–Tumor Interactions and Potential Therapeutic StrategyJuan Lu, Mengjuan Xuan, Liang Yu, Zhongyang Xie, Qingfei Chu, Shihui Wei, Tao Wang, Chen Xue, Lanjuan Li · 2026 · MedComm
- Functionalized nanopipettes for pH-gated single cell DNA delivery2025
- TBA-MLR score: a metabolic-immune prognostic biomarker for postoperative hepatocellular carcinomaYuanquan Zhao, Wei Huang, Xiwen Deng, Pengyang Li, Siyang Yao, Yongyu Yang, Xiaofeng Dong · 2025 · Frontiers in Immunology
- Hepatocellular carcinoma tumor immune microenvironment: heterogeneity and therapeutic strategiesTaishun Mao, Junqing Jiang, Ping Liu, Yongxiang Zhao, Liping Zhong, Zerui Zhang, Kaichun Wu, Limin Xia · 2026 · Hepatoma Research
- Lithocholic acid-activated VDR in macrophages promotes HCC recurrence post-ablation via SOCS3-mediated suppression of CXCL16Rumei Li, Wanrong Luo, Zhaoxi Li, Sui Zheng, Man Luo, Qiuxia Wei, Xiaotong Zhu, Wenyue Zhang, Baoming Luo · 2026 · Journal for ImmunoTherapy of Cancer
- Comparative analysis of lipid-lowering mechanisms in efficacy-divergent traditional Chinese medicines2026
- Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma亚峰 刘 · 2026 · Pharmacy Information
- Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinomaQianhui Xu, Hang Chen, Ganggang Wang, Xiaodong Wang, JieYi Shi, Yifei Cheng, Yanan Xu, Sainan Ma, Siqi Guo, Xiyang Liu et al. · 2026 · Cancer Letters
- Decoding the Biological Function of Bile Acids for Drug DiscoveryJun Yang, Xiaoguang Lei · 2026 · Accounts of Chemical Research
- Inhibition of bile acid conjugation improves cholestatic liver injury in mice with a humanized bile acid poolClaudia Daniela Fuchs, Oleksandr Petrenko, Veronika Mlitz, Emmanuel Dauda Dixon, Hubert Scharnagl, Ahmed Ghallab, Thomas Reiberger, Benjamin P. Garfinkel, Michael A Trauner · 2026 · npj gut and liver.
- Iron exacerbates congenital cholestatic liver injury via bile acid-induced ferroptosisToshiro Moroishi, Yudai Ohta, Yohei Kanamori, Ayato Maeda, Mohammad Saleh, Akihiro Nita, Takashi Matsumoto, Keiichi I. Nakayama · 2025 · Research Square
- Gut microbiota-metabolism-immunity axis: a novel perspective of traditional Chinese medicine in hepatocellular carcinoma treatmentXuemei Zhang, Liming Zheng, Jia Shi, Shihan Yu, Wenlan Zheng, Hao Liu, Zhengzheng Wu, Hai Feng, Yueqiu Gao, Zhuo Yu · 2026 · Chinese Medicine
- Preoperative albumin-bilirubin grade combined with sarcopenia predicts long-term outcomes after laparoscopic gastrectomy for advanced gastric cancer2025
- A Translational Model of MASLD-Associated HFpEF Defines Mitochondrial Dysfunction and Cardiac Plasticity During Disease Progression and RegressionSouradipta Ganguly, Betul Beyza Gunes, Yusu Gu et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
- The gut microbiome–tumor microenvironment axis in immunotherapy response: Mechanistic insights and clinical implicationsAtul Kumar Gupta · 2026 · International Journal of Molecular and Immuno Oncology
- Signaling Pathway Remodeling and Molecular Regulation in the HCC TME: Dynamic Evolution and Clinical Therapeutic AdvancesLin Xu, Xuanhao Zhang, Hengzhou Zhu, Dong Niu, Xiaodan Zhu, Chunhui Jin · 2026 · Frontiers in Bioscience-Landmark
- The conjugation-resistant bile acid norUDCA cures liver fibrosis but impairs systemic energy metabolismIoannis Evangelakos, Esther Verkade, Julia K. Rohde, Alex Zaufel, Martin Vargek, Markus Heine, Anna Worthmann, Sebastian Graute, Marceline Manka Fuh, Karthikeyan Gunasekaran et al. · 2026 · Molecular Metabolism
- Extended-Release Immunotherapy-Eluting EmbolicsImran Shair Mohammad, Anup Kumar Patel, Steven T Rosen, Marcin Kortylewski, Jonathan Kessler, Julie Ressler, Chandana G. Lall, Catalina Guerra, Jason Chiang, Franz Edward Boas · 2026 · Cancers
- Crosstalk between CD8+ T cells and systemic bile acid metabolism shapes antiviral immunity and immunopathologyFelix Clemens Richter, Zsofia Keszei, Csilla Viczenczová, Maximilian Baumgartner, Henrique G. Colaço, Magdalena Siller, Lisa Holnsteiner, Hatoon Baazim, Anna Hofmann, Aubrey Burrett et al. · 2026 · JCI Insight
- Polysaccharides-gut microbiota interaction: mechanisms regulating the hepatocellular carcinoma immune microenvironmentWei Peng, Kai Xiong, Yuyang Zheng, Jiahan Zheng, Yuanyuan Zhong, Jihao Yang, Yuchuan Jiang · 2026 · Frontiers in Immunology
- The Role and Mechanistic Effects of Gut Microbiota Metabolites in Immunotherapy for Hepatocellular CarcinomaYau-Tuen Chan, Pengde Lu, Jiaqi Zou, Zhuofeng Jiang, Lin Xu, Ning Wang · 2026 · Cancer Biome and Targeted Therapy
- Ursodeoxycholic acid boosts treatment efficacy for hepatocellular carcinoma patients receiving immunotherapyTongsheng Yang, 郑林星, Hong Mei Wu, Tian Lan · 2025 · International Journal of Surgery
- Age differentially impacts the efficacy of booster vaccination against severe COVID-19 caused by Omicron: Enhanced vulnerability to immune imprinting in the elderly mediated by immunosenescenceKe Qiu, Qian Zhu, Dachuan Cai, Zhiling Deng, Guanhua Zha, Yunling Xue, Mingli Peng, P Hu, Hong Ren · 2026 · Genes & Diseases
- Dysbiosis-associated bile acids slam the brakes on immune checkpoint therapyChi Chun Wong, Jun Qing Yu · 2026 · Cancer Cell
- Causal Associations of Cerebrospinal Fluid and Circulating Metabolites With Malignant Brain Neoplasms: A Mendelian Randomization AnalysisXinyin Zhang, Zhicheng Wu, Jing Tan · 2026 · Brain and Behavior
- Zonated cholesterol sensing by SIRT2 drives MASLD-HCCYingting Zhang, 龙喜带, Yinkun Fu, Xinxin Tang, Hao Luo, Zhihui Zou, Wei He, Longchuan Han, Yue Li, Jing Luo et al. · 2026 · Cell Metabolism
- Acute myocardial infarction induces sex-specific, time-dependent remodeling of the gut microbiome and intestinal immune compartment in retired breeder C57BL/6N miceEszter Pal, Neda Omidi Arjenaki, Yao Lu, Jianguo Xia, Lorraine E. Chalifour · 2026 · Frontiers in Microbiomes
- Bile acids in cancer: From metabolism to immunomodulationQian Fang, Kai Markus Schneider · 2026 · Immunity
- CD47-SIRPα axis mediated by ncRNA correlates with poor prognosis, immune microenvironment dysregulation and lipid metabolism modulation in hepatocellular carcinomaHuijie Gao, Cuimin Hu, Qing Wu, Zhong-Ze Fang · 2026 · International Journal of Biological Macromolecules
- Lithocholic acid alleviates fatty liver in mice and non-human primate macaquesQi Qu, Yan Chen, Guo Shen, Xiaojiao Huang, Fang-Han Li, Xiaojun Wang, Cixiong Zhang, Zhumei Wei, Liping Xie, Jianfeng Wu et al. · 2026 · Life Metabolism
- Effect of Butyrate‐Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and TremelimumabKazuhiro Nouso, Akiko Wakuta, Shohei Shiota, Rio Fujita, Kazuya Kariyama, Atsushi Hiraoka, Masanori Atsukawa, Joji Tani, Toshifumi Tada, Shinichiro Nakamura et al. · 2026 · JGH Open
- Metabolic interactions of host-gut microbiota: Shaping the future of precision diagnosis and therapeutic discovery in gastrointestinal cancersJiaxin Zhang, Jingjing Liu, Yuan Tian, Wei Jia, Ge Zhang, Aiping Lü, Haitao Lyu · 2026 · Pharmacological Research
- Anti-Cancer Effects of Quercetin: What Role Does the Gut Microbiota Play?Guang Yi, Ying Liu, Guangye Li, Ke Chang · 2026 · Molecules
- Single-cell transcriptomics reveals a novel mechanism of RDH16 regulating immune infiltration in hepatocellular carcinoma2026
- Psychological Stress Associated Bile Acid Reprogramming Promotes Hepatocellular Carcinoma ProgressionRuijiang Zeng, Mengmeng Wang, Kang Wang et al. · 2026 · Advanced Science
- Letter to the Editor: Bile acids in cholangiocarcinoma: Dual regulation via the hippo-yes-associated protein pathway and model limitations2026
- Taurine Facilitates the Formation of Hepatocellular Carcinoma via the Bile Acid Pathway2025